Skip to main content
. 2018 Apr 3;8:5441. doi: 10.1038/s41598-018-23748-x

Table 1.

The calibration curves, linearity ranges, LODs, LOQs and recoveries of nine compounds (P = 95%, k = 2).

Compounds Regression equation R2 Linearity range(µg/ml) MDL (µg/ml) MQL (µg/ml) Recovery
Means ± U(%) RSD(%)
Clitorin y = 0.2674 × − 0.0154 0.9999 4–128 0.09 0.3 100.8 ± 0.5 3.12
Rutin y = 0.3479 × + 0.0736 0.9997 4–128 0.08 0.2 98.1 ± 0.9 3.91
Isoquercitrin y = 0.4362 × − 0.0876 0.9996 1.5–48 0.04 0.1 104.5 ± 0.1 1.32
Quercetin-3-O-D-glucosyl]-(1-2)-L-rhamnoside y = 0.3458 × − 0.3234 0.9994 5–160 0.07 0.2 98.9 ± 0.6 3.76
Kaempferol-3-O-rutinoside y = 0.4151 × − 0.0989 0.9994 2.5–120 0.12 0.4 99.8 ± 1.0 3.46
Kaempferol-7-O-β-D-glucopyranoside y = 0.7537 × − 0.8358 0.9998 2.5–80 0.04 0.1 100.7 ± 0.3 4.49
Apigenin-7-O-Glucoside y = 0.719 × − 0.3239 0.9997 2.5–80 0.07 0.2 100.2 ± 0.8 0.95
Quercetin-3-O-[2-O-(6-O-p-hydroxyl-E-coumaroyl)-D-glucosyl]-(1-2)-L-rhamnoside y = 0.3604 × − 0.2522 0.9999 6–192 0.09 0.3 96.9 ± 0.3 0.79
3-O-{2-O-[6-O-(p-hydroxyl-E-coumaroyl)-glucosyl]-(1-2)rhamnosyl kaempferol y = 0.5507 × − 0.3791 0.9998 4–128 0.05 0.1 103.3 ± 0.5 1.04
HHS Vulnerability Disclosure